FOXO3 and cancer: Other studies suggested that, at least in some cancer types including leukemia, activation of FOXO3a is initially required for apoptosis induction in response to chemotherapy, whereas its prolonged activity promotes drug resistance by increasing antioxidant defenses and DNA damage repair [112].